FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

3349811000001104: Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2105381000001114 Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2105391000001111 Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Is a Generic Femoston 2/10mg tablets true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Progesterone false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Estrogen false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Is a Femoston 2/10 true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has manufactured dose form Dose form not applicable (qualifier value) false Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Has active ingredient Synthetic progestogen false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) 84 tablet 3 x (14 tablets + 14 tablets) Is pack of False Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier
Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) 84 tablet 3 x (14 tablets + 14 tablets) Has AMP True Femoston 2/10mg tablets (Viatris UK Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start